Follow
Vivek Verma
Vivek Verma
Verma Radiation Oncology Consulting (VROC)
No verified email
Title
Cited by
Cited by
Year
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
WSME Theelen, D Chen, V Verma, BP Hobbs, HMU Peulen, JGJV Aerts, ...
The Lancet Respiratory Medicine 9 (5), 467-475, 2021
3442021
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
V Verma, T Sprave, W Haque, CB Simone, JY Chang, JW Welsh, ...
Journal for immunotherapy of cancer 6, 1-15, 2018
2762018
Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy
W Haque, V Verma, S Hatch, V Suzanne Klimberg, E Brian Butler, BS Teh
Breast cancer research and treatment 170, 559-567, 2018
2662018
A systematic review of the cost and cost‐effectiveness studies of proton radiotherapy
V Verma, MV Mishra, MP Mehta
Cancer 122 (10), 1483-1501, 2016
2202016
Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer
SH Lin, BP Hobbs, V Verma, RS Tidwell, GL Smith, X Lei, EM Corsini, ...
Journal of Clinical Oncology 38 (14), 1569, 2020
2022020
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified …
JY Chang, RJ Mehran, L Feng, V Verma, Z Liao, JW Welsh, SH Lin, ...
The Lancet Oncology 22 (10), 1448-1457, 2021
1962021
Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy
T Sprave, V Verma, R Förster, I Schlampp, T Bruckner, T Bostel, SE Welte, ...
Radiotherapy and Oncology 128 (2), 274-282, 2018
1942018
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
J Welsh, H Menon, D Chen, V Verma, C Tang, M Altan, K Hess, ...
Journal for immunotherapy of cancer 8 (2), 2020
1742020
Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study
CG Rusthoven, M Yamamoto, D Bernhardt, DE Smith, D Gao, T Serizawa, ...
JAMA oncology 6 (7), 1028-1037, 2020
1522020
Proton beam radiotherapy and concurrent chemotherapy for unresectable stage III non–small cell lung cancer: final results of a phase 2 study
JY Chang, V Verma, M Li, W Zhang, R Komaki, C Lu, PK Allen, Z Liao, ...
JAMA oncology 3 (8), e172032-e172032, 2017
1412017
A systematic review and meta-analysis of cancer patients affected by a novel coronavirus
BP Venkatesulu, VT Chandrasekar, P Girdhar, P Advani, A Sharma, ...
JNCI cancer spectrum 5 (2), pkaa102, 2021
1372021
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort
M Stahl, M DeVeaux, P Montesinos, R Itzykson, EK Ritchie, MA Sekeres, ...
Blood advances 2 (8), 923-932, 2018
1322018
Role of radiation therapy in modulation of the tumor stroma and microenvironment
H Menon, R Ramapriyan, TR Cushman, V Verma, HH Kim, C Atalar, ...
Frontiers in immunology 10, 432757, 2019
1312019
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer
XS Wang, YF Bai, V Verma, RL Yu, W Tian, R Ao, Y Deng, XQ Zhu, H Liu, ...
JNCI: Journal of the National Cancer Institute 115 (6), 742-748, 2023
1272023
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
M Stahl, M DeVeaux, T De Witte, J Neukirchen, MA Sekeres, AM Brunner, ...
Blood advances 2 (14), 1765-1772, 2018
1202018
Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China
W Wei, D Zheng, Y Lei, S Wu, V Verma, Y Liu, X Wei, J Bi, D Hu, G Han
Radiotherapy and Oncology 148, 203-210, 2020
1182020
The rise of radiomics and implications for oncologic management
V Verma, CB Simone, S Krishnan, SH Lin, J Yang, SM Hahn
JNCI: Journal of the National Cancer Institute 109 (7), djx055, 2017
1182017
Quality of life and patient-reported outcomes following proton radiation therapy: a systematic review
V Verma, CB Simone, MV Mishra
JNCI: Journal of the National Cancer Institute 110 (4), 341-353, 2018
1072018
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
H Menon, D Chen, R Ramapriyan, V Verma, HB Barsoumian, ...
Journal for immunotherapy of cancer 7, 1-9, 2019
1052019
Phase II trial of ipilimumab with stereotactic radiation therapy for metastatic disease: outcomes, toxicities, and low-dose radiation–related abscopal responses
JW Welsh, C Tang, P De Groot, A Naing, KR Hess, JV Heymach, ...
Cancer immunology research 7 (12), 1903-1909, 2019
982019
The system can't perform the operation now. Try again later.
Articles 1–20